We’re not even halfway through March, and it seems the month has already been marked with an abundance of failed drug studies. The most recent: Three potential cancer drugs — two from Pfizer and one from Roche — didn’t pan out in late stage clinical trials. Continue reading Cancer Drugs from Pfizer and Roche Fail in Clinical Trials Cancer Drugs from Pfizer and Roche Fail in Clinical Trials originally appeared on DailyFinance on Fri, 12 Mar 2010 09:41:00. Filed Under: Company News , Healthcare , Pfizer , Astrazeneca Permalink | Tweet this! | Comments

Read more here: 
Cancer Drugs from Pfizer and Roche Fail in Clinical Trials

Abbott Labs announced it would acquire Facet Biotech for $27 per share. The friendly deal, which will enhance Abbott’s pharmaceutical pipeline, is expected to close in the second quarter of this year and has been approved by the boards of both companies. Continue reading Abbott Experiments with a $450 Million Deal for Facet Abbott Experiments with a $450 Million Deal for Facet originally appeared on DailyFinance on Wed, 10 Mar 2010 11:30:00. Filed Under: Company News , Healthcare , Bristol-Myers Squibb , Abbott Permalink | Tweet this! | Comments

View original post here:
Abbott Experiments with a $450 Million Deal for Facet

InterMune trading was halted Tuesday, as a Food and Drug Administration panel reviews the pharma’s experimental drug pirfenidone, intended to treat idiopathic pulmonary fibrosis, a fatal disease in which the lungs scar without discernible cause. Continue reading InterMune Trading Halts, Pending FDA Review of Respiratory Drug InterMune Trading Halts, Pending FDA Review of Respiratory Drug originally appeared on DailyFinance on Tue, 09 Mar 2010 11:49:00. Filed Under: Healthcare Permalink | Tweet this! | Comments

Original post: 
InterMune Trading Halts, Pending FDA Review of Respiratory Drug

The drugmaker said that its experimental drug Recentin failed to show it was better than Roche’s Avastin as a treatment for colon cancer in a late-stage, head-to-head trial. But it wasn’t worse, either. Investors focused on the former and pushed AstraZeneca’s stock down. Continue reading AstraZeneca Shares Drop on Failed Colon Cancer Drug Trial AstraZeneca Shares Drop on Failed Colon Cancer Drug Trial originally appeared on DailyFinance on Mon, 08 Mar 2010 13:41:00. Filed Under: Company News , Healthcare , Astrazeneca Permalink | Tweet this! | Comments

Go here to see the original:
AstraZeneca Shares Drop on Failed Colon Cancer Drug Trial

Unwilling to see his landmark healthcare reform legislation die, President Barack Obama on Wednesday urged lawmakers to pass the bill, according to Aol News. The site reported that the president called for an “up or down” vote on a plan that he said incorporated “the best ideas from Democrats and Republicans.” For the full story on Aol News, click here . Continue reading Obama Calls for ‘Up or Down’ Vote on Healthcare Obama Calls for ‘Up or Down’ Vote on Healthcare originally appeared on DailyFinance on Wed, 03 Mar 2010 20:00:00. Filed Under: Healthcare Permalink | Tweet this! | Comments

See the original post here: 
Obama Calls for ‘Up or Down’ Vote on Healthcare

Two new books raise some deep questions about the American concept of mental health: One is a searing investigation of how we export, not just our drugs, but our idea of mental illness. The other is the upcoming revision of the psychiatric diagnostic manual, which proposed some very necessary changes to the standards of treatment. Continue reading Drugged and Dosed: Do Americans Take Too Many Mind-Altering Meds? Drugged and Dosed: Do Americans Take Too Many Mind-Altering Meds? originally appeared on DailyFinance on Wed, 03 Mar 2010 08:00:00. Filed Under: Healthcare , GlaxoSmithKline Permalink | Tweet this! | Comments

More here:
Drugged and Dosed: Do Americans Take Too Many Mind-Altering Meds?

Bush-era Supreme Court decisions have left the EPA hamstrung with regards to protecting Americans’ rights to drink clean water. Today, more than one in three Americans ultimately get their drinking water from sources that may no longer be protected by the Clean Water Act. Continue reading Legal Briefing: Want to Pollute? Just Dump in a Stream, Not a River Legal Briefing: Want to Pollute? Just Dump in a Stream, Not a River originally appeared on DailyFinance on Mon, 01 Mar 2010 13:13:00. Filed Under: Columns Permalink | Tweet this! | Comments

Original post:
Legal Briefing: Want to Pollute? Just Dump in a Stream, Not a River

The AIG-Prudential Plc deal was the big news on Monday, but pharmaceuticals have been busy as well. However, dealmaking wasn’t the only factor moving the sector today. Several drug approvals, some studies and one “going-concern” warning also affected it. Continue reading Pharma Today: Deals, Drug News, and a ‘Going Concern’ Warning Pharma Today: Deals, Drug News, and a ‘Going Concern’ Warning originally appeared on DailyFinance on Mon, 01 Mar 2010 13:30:00. Filed Under: Company News , Technology , Investing , Healthcare Permalink | Tweet this! | Comments

Read more from the original source:
Pharma Today: Deals, Drug News, and a ‘Going Concern’ Warning

To keep scientific breakthroughs from getting snagged in the morass of federal regulations, the NIH and the FDA announced an initative to get science and law in closer sync. Unfortunately, the joint venture has a shoestring budget. Continue reading FDA, NIH Aim to Push New Breakthroughs, but the Budget’s Tight FDA, NIH Aim to Push New Breakthroughs, but the Budget’s Tight originally appeared on DailyFinance on Wed, 24 Feb 2010 15:47:00. Filed Under: Technology , Healthcare Permalink | Tweet this! | Comments

See more here:
FDA, NIH Aim to Push New Breakthroughs, but the Budget’s Tight

Akio Toyoda appeared Wednesday before lawmakers in Washington to explain recalls of millions of Toyota vehicles. He apologized for the failures to properly acknowledge and address the problems, but at times his questioners seemed skeptical and even frustrated. Continue reading Toyota’s Chief to Congress: ‘I Take Full Responsibility’ Toyota’s Chief to Congress: ‘I Take Full Responsibility’ originally appeared on DailyFinance on Wed, 24 Feb 2010 16:57:00. Filed Under: Company News , Toyota , Autos Permalink | Tweet this! | Comments

Go here to see the original: 
Toyota’s Chief to Congress: ‘I Take Full Responsibility’